Abiraterone Acetate/Prednisolone Acetate

醋酸阿比特龙/醋酸泼尼松龙

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAbiraterone Acetate/Prednisolone Acetate
Drug Alias NameAbirasolon
ClassificationSmall molecules > Steroids
Mechanisms of ActionSteroid 17-alpha-hydroxylase inhibitorsGlucocorticoid receptor agonists
TargetsSteroid 17-alpha-hydroxylaseGlucocorticoid receptor
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date2022/08/09
Country/TerritoryGermany
CombinationsYes Abiraterone AcetatePrednisolone Acetate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAristo Pharma Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesAristo Pharma Gmbh
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A